Cargando…
3,5-Bis(arylidene)-4-piperidones as potential dengue protease inhibitors
Dengue is a severe mosquito-borne viral infection causing half a million deaths annually. Dengue virus NS2B/NS3 protease is a validated target for anti-dengue drug design. A series of hitherto unreported 3,5-bis(arylidene)-4-piperidones analogues 4a—4j were synthesized and screened in silico against...
Autores principales: | Osman, Hasnah, Idris, Nor Hashima, Kamarulzaman, Ezatul Ezleen, Wahab, Habibah A., Hassan, Mohd. Zaheen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518655/ https://www.ncbi.nlm.nih.gov/pubmed/28752033 http://dx.doi.org/10.1016/j.apsb.2017.04.009 |
Ejemplares similares
-
Assessing the potential of NS2B/NS3 protease inhibitors biomarker in curbing dengue virus infections: In silico vs. In vitro approach
por: Norshidah, Harun, et al.
Publicado: (2023) -
Comparative QSAR Analysis of 3,5-bis (Arylidene)-4-Piperidone Derivatives: the Development of Predictive Cytotoxicity Models
por: Edraki, Najmeh, et al.
Publicado: (2016) -
Computational study of nitro-benzylidene phenazine as dengue virus-2 NS2B-NS3 protease inhibitor
por: Salin, Nurul Hanim, et al.
Publicado: (2022) -
Trifluoromethyl-substituted 3,5-bis(arylidene)-4-piperidones as potential anti-hepatoma and anti-inflammation agents by inhibiting NF-кB activation
por: Cong, Wei, et al.
Publicado: (2021) -
1-Benzyl-3,5-bis(2-thienylmethylene)-4-piperidone
por: Sun, Ju-feng, et al.
Publicado: (2009)